Seismic Therapeutic scientist Andita Newton in the lab (courtesy Seismic)
Seismic raises $121M to enter immunology space spotlighted by argenx, Immunovant and others
Seismic Therapeutic has raised $121 million in a Series B, about 20% larger than it had originally sought, to enter the clinic with two biologics created using its machine learning tools, it said Monday morning.
The financing will help the biotech speed forward at the intersection of two burgeoning fields of biopharma R&D — machine learning and a crowded race to create the next big immunology medicines.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
